1887

Journal of General Virology header logo

Volume 104, Issue 11

The hepatitis E virus ORF1 hypervariable region confers partial cyclophilin dependency Open Access

Abstract

Hepatitis E virus (HEV) is an emerging pathogen responsible for more than 20 million cases of acute hepatitis globally per annum. Healthy individuals typically have a self-limiting infection, but mortality rates in some populations such as pregnant women can reach 30 %. A detailed understanding of the virus lifecycle is lacking, mainly due to limitations in experimental systems. In this regard, the cyclophilins are an important family of proteins that have peptidyl-prolyl isomerase activity and play roles in the replication of a number of positive-sense RNA viruses, including hepatotropic viruses such as hepatitis C virus (HCV). Cyclophilins A and B (CypA/B) are the two most abundant Cyps in hepatocytes and are therefore potential targets for pan-viral therapeutics. Here, we investigated the importance of CypA and CypB for HEV genome replication using sub-genomic replicons. Using a combination of pharmacological inhibition by cyclosporine A (CsA), and silencing by small hairpin RNA we find that CypA and CypB are not essential for HEV replication. However, we find that silencing of CypB reduces replication of some HEV isolates in some cells. Furthermore, sensitivity to Cyp silencing appears to be partly conferred by the sequence within the hypervariable region of the viral polyprotein. These data suggest HEV is atypical in its requirements for cyclophilin for viral genome replication and that this phenomenon could be genotype- and sequence-specific.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): cyclosporine , HEV , replication complex and replicon
Funding
This study was supported by the:
  • Medical Research Council (Award MR/S007229/1)
    • Principle Award Recipient: MorganR Herod
© 2023 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001919
2023-11-09
2024-05-11
Loading full text...

Full text loading...

/deliver/fulltext/jgv/104/11/jgv001919.html?itemId=/content/journal/jgv/10.1099/jgv.0.001919&mimeType=html&fmt=ahah

References

  1. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012; 55:988–997 [View Article] [PubMed]
     [Google Scholar]
  2. Purdy MA, Harrison TJ, Jameel S, Meng X-J, Okamoto H et al. ICTV virus taxonomy profile: Hepeviridae. J Gen Virol 2017; 98:2645–2646 [View Article] [PubMed]
     [Google Scholar]
  3. Purdy MA, Drexler JF, Meng X-J, Norder H, Okamoto H et al. ICTV virus taxonomy profile: Hepeviridae 2022. J Gen Virol 2022; 103:e0.001778 [View Article]
     [Google Scholar]
  4. Smith DB, Izopet J, Nicot F, Simmonds P, Jameel S et al. Update: proposed reference sequences for subtypes of hepatitis E virus (species Orthohepevirus A). J Gen Virol 2020; 101:692–698 [View Article] [PubMed]
     [Google Scholar]
  5. Syed SF, Zhao Q, Umer M, Alagawany M, Ujjan IA et al. Past, present and future of hepatitis E virus infection: zoonotic perspectives. Microb Pathog 2018; 119:103–108 [View Article] [PubMed]
     [Google Scholar]
  6. Teshale EH, Grytdal SP, Howard C, Barry V, Kamili S et al. Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin Infect Dis 2010; 50:1006–1010 [View Article] [PubMed]
     [Google Scholar]
  7. Li P, Ji Y, Li Y, Ma Z, Pan Q. Estimating the global prevalence of hepatitis E virus in swine and pork products. One Health 2022; 14:100362 [View Article] [PubMed]
     [Google Scholar]
  8. Pallerla SR, Schembecker S, Meyer CG, Linh LTK, Johne R et al. Hepatitis E virus genome detection in commercial pork livers and pork meat products in Germany. J Viral Hepat 2022; 28:196–204 [View Article] [PubMed]
     [Google Scholar]
  9. Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003; 10:61–69 [View Article] [PubMed]
     [Google Scholar]
  10. LeDesma R, Nimgaonkar I, Ploss A. Hepatitis E virus replication. Viruses 2019; 11:719 [View Article] [PubMed]
     [Google Scholar]
  11. Montpellier C, Wychowski C, Sayed IM, Meunier J-C, Saliou J-M et al. Hepatitis E virus lifecycle and identification of 3 forms of the ORF2 capsid protein. Gastroenterology 2018; 154:211–223 [View Article] [PubMed]
     [Google Scholar]
  12. Nair VP, Anang S, Subramani C, Madhvi A, Bakshi K et al. Endoplasmic reticulum stress induced synthesis of a novel viral factor mediates efficient replication of genotype-1 hepatitis E virus. PLoS Pathog 2016; 12:e1005521 [View Article] [PubMed]
     [Google Scholar]
  13. Koonin EV, Gorbalenya AE, Purdy MA, Rozanov MN, Reyes GR et al. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Microbiology 1992; 89:8259–8263 [View Article] [PubMed]
     [Google Scholar]
  14. Fieulaine S, Tubiana T, Bressanelli S. De novo modelling of HEV replication polyprotein: Five-domain breakdown and involvement of flexibility in functional regulation. Virology 2023; 128:128–140 [View Article] [PubMed]
     [Google Scholar]
  15. LeDesma R, Heller B, Biswas A, Maya S, Gili S et al. Structural features stabilized by divalent cation coordination within hepatitis E virus ORF1 are critical for viral replication. eLife 2023; 12:e80529 [View Article] [PubMed]
     [Google Scholar]
  16. Sehgal D, Thomas S, Chakraborty M, Jameel S. Expression and processing of the Hepatitis E virus ORF1 nonstructural polyprotein. Virol J 2006; 3:38 [View Article] [PubMed]
     [Google Scholar]
  17. Parvez MK. The hepatitis E virus ORF1 “X-domain” residues form a putative macrodomain protein/Appr-1″-pase catalytic-site, critical for viral RNA replication. Gene 2015; 566:47–53 [View Article] [PubMed]
     [Google Scholar]
  18. Rehman S, Kapur N, Durgapal H, Panda SK. Subcellular localization of hepatitis E virus (HEV) replicase. Virology 2008; 370:77–92 [View Article] [PubMed]
     [Google Scholar]
  19. Hooda P, Ishtikhar M, Saraswat S, Bhatia P, Mishra D et al. Biochemical and biophysical characterisation of the hepatitis E virus guanine-7-methyltransferase. Molecules 2022; 27:1505 [View Article] [PubMed]
     [Google Scholar]
  20. Karpe YA, Lole KS. RNA 5’-triphosphatase activity of the hepatitis E virus helicase domain. J Virol 2010; 94:9637–9641 [View Article] [PubMed]
     [Google Scholar]
  21. Colpitts CC, Ridewood S, Schneiderman B, Warne J, Tabata K et al. Hepatitis C virus exploits cyclophilin A to evade PKR. eLife 2020; 9:e52237 [View Article] [PubMed]
     [Google Scholar]
  22. Daijun Z, Qiang M, Jintao L, Haiyang H. Cyclophilin A and viral infections. Biochem Biophys Res Commun 2012; 424:647–650 [View Article] [PubMed]
     [Google Scholar]
  23. Beauchesne PR, Chung NSC, Wasan KM. Cyclosporine A: a review of current oral and intravenous delivery systems. Drug Dev Ind Pharm 2007; 33:211–220 [View Article] [PubMed]
     [Google Scholar]
  24. Wu X, Thi VL, Liu P, Takacs CN, Xiang K et al. Pan-genotype hepatitis E virus replication in stem cell-derived hepatocellular systems. Gastroenterology 2018; 154:663–674 [View Article] [PubMed]
     [Google Scholar]
  25. Wang Y, Zhou X, Debing Y, Chen K, Van Der Laan LJW et al. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus. Gastroenterology 2014; 146:1775–1783 [View Article] [PubMed]
     [Google Scholar]
  26. Emerson SU, Nguyen H, Graff J, Stephany DA, Brockington A et al. In vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent protein. J Virol 2004; 78:4838–4846 [View Article] [PubMed]
     [Google Scholar]
  27. Herod MR, Ward JC, Tuplin A, Harris M, Stonehouse NJ et al. Positive strand RNA viruses differ in the constraints they place on the folding of their negative strand. RNA 2022; 28:1359–1376 [View Article] [PubMed]
     [Google Scholar]
  28. Shiota T, Li T-C, Yoshizaki S, Kato T, Wakita T et al. The hepatitis E virus capsid C-terminal region is essential for the viral life cycle: implication for viral genome encapsidation and particle stabilization. J Virol 2013; 87:6031–6036 [View Article] [PubMed]
     [Google Scholar]
  29. Szkolnicka D, Pollán A, Da Silva N, Oechslin N, Gouttenoire J et al. Recombinant hepatitis E viruses harboring tags in the ORF1 protein. J Virol 2019; 93:e00459-19 [View Article] [PubMed]
     [Google Scholar]
  30. Fernandes F, Ansari IH, Striker R. Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A. PLOS ONE 2010; 5:e0009815 [View Article] [PubMed]
     [Google Scholar]
  31. Wang P, Heitman J. The cyclophilins. Genome Biol 2005; 6:e200567226 [View Article] [PubMed]
     [Google Scholar]
  32. Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 1984; 226:544–547 [View Article] [PubMed]
     [Google Scholar]
  33. Sumpter R, Loo Y-M, Foy E, Li K, Yoneyama M et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 2005; 79:2689–2699 [View Article] [PubMed]
     [Google Scholar]
  34. Teimourpour R, Meshkat Z, Gholoubi A, Nomani H, Rostami S. Viral load analysis of hepatitis C virus in Huh7.5 cell culture system. Jundishapur J Microbiol 2015; 8:e19279 [View Article] [PubMed]
     [Google Scholar]
  35. Liu J-P, Ye L, Wang X, Li J-L, Ho W-Z. Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes. Transpl Infect Dis 2010; 13:24–32 [View Article] [PubMed]
     [Google Scholar]
  36. Andrés D, Cascales M. Novel mechanism of vitamin E protection against cyclosporine A cytotoxicity in cultured rat hepatocytes. Biochem Pharmacol 2002; 64:267–276 [View Article] [PubMed]
     [Google Scholar]
  37. Kambara H, Tani H, Mori Y, Abe T, Katoh H et al. Involvement of cyclophilin B in the replication of Japanese encephalitis virus. Virology 2011; 412:211–219 [View Article] [PubMed]
     [Google Scholar]
  38. Morohashi K, Sahara H, Watashi K, Iwabata K, Sunoki T et al. Cyclosporin A associated helicase-like protein facilitates the association of hepatitis C virus RNA polymerase with its cellular cyclophilin B. PLoS One 2011; 6:e18285 [View Article] [PubMed]
     [Google Scholar]
  39. Shukla P, Nguyen HT, Faulk K, Mather K, Torian U et al. Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination. J Virol 2012; 80:5697–5707 [View Article] [PubMed]
     [Google Scholar]
  40. Watashi K, Ishii N, Hijikata M, Inoue D, Murata T et al. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol Cell 2005; 19:111–122 [View Article] [PubMed]
     [Google Scholar]
  41. Chen S, Harris M. Mutational analysis reveals a novel role for hepatitis C virus NS5A domain I in cyclophilin-dependent genome replication. J Gen Virol 2023; 104:e001886 [View Article] [PubMed]
     [Google Scholar]
  42. Scholte FEM, Tas A, Martina BEE, Cordioli P, Narayanan K et al. Characterization of synthetic chikungunya viruses based on the consensus sequence of recent E1-226V isolates. PLoS One 2013; 8:e0071047 [View Article] [PubMed]
     [Google Scholar]
  43. Esser-Nobis K, Harak C, Schult P, Kusov Y, Lohmann V. Novel perspectives for hepatitis A virus therapy revealed by comparative analysis of hepatitis C virus and hepatitis A virus RNA replication. Hepatology 2015; 62:397–408 [View Article] [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001919
Loading
The hepatitis E virus ORF1 hypervariable region confers partial cyclophilin dependency
J. Gen. Virol. 104, 001919 (2023); https://doi.org/10.1099/jgv.0.001919
/content/journal/jgv/10.1099/jgv.0.001919
/content/journal/jgv/10.1099/jgv.0.001919
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error